Skip to content

Phase 1/1b Study of BMS-986463 in Advanced Malignant Tumors

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-523067-38-01
Enrollment
14
Registered
2026-07-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Malignant Tumors; High-grade Serous Ovarian Carcinoma (HGSOC), Non-small Cell Lung Cancer (NSCLC), Uterine Serous Carcinoma (USC)

Interventions

None listed

Sponsors

Bristol-Myers Squibb Services Unlimited Company
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Outcome results

None listed

Source: EU CTIS · Data processed: Jul 24, 2026